Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Nov 18, 2022

Accession no.
0001209191-22-057947
Filed
Nov 18, 2022
Trade date
Sep 27-Oct 31, 2022
Filing delay
52 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 25 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.25K. It was filed 52 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 27, 2022Common StockPPurchaseAcquired+20$2.57+$51.418,308Direct
Sep 28, 2022Common StockPPurchaseAcquired+20$2.52+$50.418,328Direct
Sep 29, 2022Common StockPPurchaseAcquired+20$2.51+$50.218,348Direct
Sep 30, 2022Common StockPPurchaseAcquired+20$2.61+$52.218,368Direct
Oct 3, 2022Common StockPPurchaseAcquired+20$2.54+$50.818,388Direct
Oct 4, 2022Common StockPPurchaseAcquired+20$2.61+$52.218,408Direct
Oct 5, 2022Common StockPPurchaseAcquired+20$2.58+$51.618,428Direct
Oct 6, 2022Common StockPPurchaseAcquired+20$2.65+$5318,448Direct
Oct 7, 2022Common StockPPurchaseAcquired+20$2.66+$53.218,468Direct
Oct 10, 2022Common StockPPurchaseAcquired+20$2.53+$50.618,488Direct
Oct 11, 2022Common StockPPurchaseAcquired+20$2.48+$49.618,508Direct
Oct 12, 2022Common StockPPurchaseAcquired+20$2.49+$49.818,528Direct
Oct 13, 2022Common StockPPurchaseAcquired+20$2.38+$47.618,548Direct
Oct 14, 2022Common StockPPurchaseAcquired+20$2.31+$46.218,568Direct
Oct 17, 2022Common StockPPurchaseAcquired+20$2.33+$46.618,588Direct
Oct 18, 2022Common StockPPurchaseAcquired+20$2.46+$49.218,608Direct
Oct 19, 2022Common StockPPurchaseAcquired+20$2.42+$48.418,628Direct
Oct 20, 2022Common StockPPurchaseAcquired+20$2.44+$48.818,648Direct
Oct 21, 2022Common StockPPurchaseAcquired+20$2.49+$49.818,668Direct
Oct 24, 2022Common StockPPurchaseAcquired+20$2.38+$47.618,688Direct
Oct 25, 2022Common StockPPurchaseAcquired+20$2.44+$48.818,708Direct
Oct 26, 2022Common StockPPurchaseAcquired+20$2.42+$48.418,728Direct
Oct 27, 2022Common StockPPurchaseAcquired+20$2.49+$49.818,748Direct
Oct 28, 2022Common StockPPurchaseAcquired+20$2.52+$50.418,768Direct
Oct 31, 2022Common StockPPurchaseAcquired+20$2.54+$50.818,788Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)